Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • A Study to Test How Safe Budoprutug Is and How Well It Works in Patients with Immune Thrombocytopenia

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Greece Spain
  • A Follow-up Study of Mezagitamab in Adults with Chronic Primary Immune Thrombocytopenia to Evaluate Long-term Safety and Effectiveness

    Recruiting

    3 1 1
    Investigated diseases:
    Bulgaria Croatia Czechia France Germany Greece +6
  • A study to evaluate the safety and effectiveness of tafasitamab in adults with autoimmune thrombocytopenia or autoimmune hemolytic anemia

    Recruiting

    4 1 1 1
    Investigated drugs:
    France Italy The Netherlands Spain
  • A Study of Mezagitamab Compared to Placebo for Adults with Chronic Primary Immune Thrombocytopenia

    Recruiting

    3 1
    Investigated diseases:
    Bulgaria Croatia Czechia France Germany Greece +6
  • Study of oral rilzabrutinib for adults with immune thrombocytopenia who did not respond to first-line treatment

    Recruiting

    3 1 1
    Investigated drugs:
    Austria Czechia France Germany Hungary Italy +2
  • Study of NVG-2089 given by intravenous infusion in patients with immune thrombocytopenia to evaluate safety and effectiveness

    Recruiting

    2 1 1 1
    Investigated diseases:
    Greece Poland Spain
  • Study of efgartigimod given by IV infusion in adolescents aged 12-17 years with chronic immune thrombocytopenia

    Recruiting

    4 1
    Investigated diseases:
    Investigated drugs:
    France Germany Hungary Italy Lithuania Poland +2
  • Study on the Safety and Effectiveness of Pirtobrutinib for Adults with Immune Thrombocytopenia

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Denmark France Italy Norway Poland Spain
  • Study on the Safety and Effectiveness of Belantamab Mafodotin for Adults with Primary Immune Thrombocytopenia Previously Treated with Standard Medications

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Greece
  • Study on the Effectiveness and Safety of Efgartigimod IV for Adults with Primary Immune Thrombocytopenia

    Recruiting

    3 1 1
    Investigated drugs:
    Austria Bulgaria Croatia Czechia France Germany +8